Characteristic analysis of adverse reactions of finerenone: an in-depth analysis from WHO-VigiAccess
IntroductionFinerenone is a novel non-steroidal mineralocorticoid receptor antagonist that has shown promise in the treatment of chronic kidney disease and heart failure. As its clinical use expands, understanding the adverse events associated with finerenone becomes crucial to ensuring patient safe...
Saved in:
| Main Authors: | Hongxuan Fan, Zhuolin Huang, Yafen Yang, Jiahui Li, Boda Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1545148/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse event profile of lomustine and temozolomide: a descriptive analysis from WHO-VigiAccess
by: Hua Luo, et al.
Published: (2025-03-01) -
Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess
by: Tongnan Yin, et al.
Published: (2025-03-01) -
Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccess
by: Zeyu Wang, et al.
Published: (2025-05-01) -
The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases
by: Zhaorui Wang, et al.
Published: (2025-03-01) -
A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases
by: Haoxiang Hu, et al.
Published: (2025-04-01)